CHM chimeric therapeutics limited

Ann: Appointment of VP Clinical Operations & Data Management, page-5

  1. 1,303 Posts.
    lightbulb Created with Sketch. 3966
    Agreed, although I don't think it'll take as long as it has taken IMU for the market to wake up.

    Just a reminder, IPO only happened 1.5 years ago (MC is currently just over A$40 million with 425 million SOI).

    CHM's licensed CORE-NK platform already produced clinical safety and efficacy data in a P1 trial:

    https://hotcopper.com.au/data/attachments/4483/4483016-d55c5b9290f58581f396a3acc2162367.jpg

    https://chimerictherapeutics.com/wp-content/uploads/2022/06/CHI4766_Chimeric-Therapeutics_Newsletter_June22_Web-FA.pdf

    https://hotcopper.com.au/data/attachments/4483/4483019-aca3fe9fcf797983ae59bff2483a314a.jpg

    That is in addition to the company's own ongoing P1 CAR-T trial.

    Depending on the results, https://hotcopper.com.au/data/attachments/4483/4483042-17ab982248f8959a59eef0768cd594d8.jpg (https://chimerictherapeutics.com/our-pipeline/) and Project Orbis may also be an option if the results of patient #8 can be repeated.

    All that for A$40 million.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $10.07M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $11.08K 2.623M

Buyers (Bids)

No. Vol. Price($)
8 4706271 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14960701 24
View Market Depth
Last trade - 11.14am 23/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.